“…The antibodies used included allophycocyanin (APC)-cyanin (Cy)7- conjugated anti-CD4 (RPA-T4), peridinin chlorophyll protein (PerCP)-Cy5.5-conjugated anti-CD25 (M-A251), phycoerythrin(PE)-Cy7-conjugated anti-CD45RO (UCHL1), Brilliant Violet 421-conjugated anti-CCR4 (L291H4), PE-conjugated anti-CCR7 (G043H7), FITC-conjugated anti-mouse IgG1 (PMG1-1), FITC-conjugated anti-mouse IgM (RMM-1) (BioLegend, San Diego, CA, USA), anti-human CD15s (CSLEX1(RUO)) (BD Pharmingen, San Jose, CA, USA), anti-sialyl 6-sulfo Le x (G152, mouse IgM) 17 , and anti-cyclic sialyl 6-sulfo Le x (G159, mouse IgG1) 17 . Leukocytes were treated with the FOXP3 Fix/Perm buffer set (BioLegend) to increase the permeability of cells, before being stained with Alexa Fluor 647-conjugated anti-FOXP3 (259D) (BioLegend).…”